US 8962856
Modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/427A61P
Quick answer
US patent 8962856 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/427, A61P, A61P1/00, A61P1/12